De novo hemorrhagic sporadic cavernous malformation appearance after COVID-19 respiratory infection: illustrative case

Carmen R. Holmes, Giuseppe Lanzino, Kelly D. Flemming

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND Little is known about whether coronavirus disease 2019 (COVID-19) influences cavernous malformation (CM) formation or hemorrhage risk. OBSERVATIONS The authors present the case of a 31-year-old patient who developed a hemorrhagic, de novo CM in the setting of a developmental venous anomaly within 3 months of COVID-19 respiratory disease. The authors speculate that COVID-19 disease stimulated formation of the CM through TLR4 inflammatory pathways and subsequently led to the hemorrhagic presentation because of hypercoagulability related to the disease. LESSONS This case raises the possibility that COVID-19 may be a risk factor for de novo development of CMs in predisposed patients.

Original languageEnglish (US)
Article numberCASE21543
JournalJournal of Neurosurgery: Case Lessons
Volume2
Issue number19
DOIs
StatePublished - Nov 2021

Keywords

  • COVID-19
  • cavernous angioma
  • cavernous malformation
  • inflammation

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Fingerprint

Dive into the research topics of 'De novo hemorrhagic sporadic cavernous malformation appearance after COVID-19 respiratory infection: illustrative case'. Together they form a unique fingerprint.

Cite this